Biotechnology News and Research

RSS

Scientists use electron microscopes to study mechanism of perforin protein to punch holes in rogue cells

Scientists from the UK and Australia have seen the human immune system's assassin a protein called perforin in action for the first time. The UK team, funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Wellcome Trust, is based at Birkbeck College where they used powerful electron microscopes to study the mechanism that perforin uses to punch holes in rogue cells.

1 Nov 2010

Anadys presents data of ANA598 for hepatitis C treatment at AASLD Annual Meeting

Anadys Pharmaceuticals, Inc. today announced the ANA598 data to be presented at the 61st Annual Meeting of the American Association for the Study of Liver Disease (AASLD) in Boston, MA.

1 Nov 2010

2010 Mid-Atlantic Bio a great kick-off for hosting 2011 BIO International Convention

The 2010 Mid-Atlantic Bio today completed another successful conference hosting 728 registrants from 22 states and 4 countries, with more than 400 companies and 50 qualified investors participating. Dedicated to promoting the biotechnology industry in the Mid-Atlantic region, the conference is hosted collectively by the region's most influential bioscience and investor associations, the Mid-Atlantic Venture Association (MAVA), the Tech Council of Maryland/MdBio (MdBio) and the Virginia Biotechnology Association (VaBIO).

30 Oct 2010

Special issue of Ecopsychology outlines woman's self-perception and behavior

Women experience and interact with their natural surroundings in ways that differ from men. The way in which those differences affect a woman's sense of self, body image, and drive to protect and preserve the environment are explored in a thought-provoking special issue of Ecopsychology, a peer-reviewed, online journal published by Mary Ann Liebert, Inc.

30 Oct 2010

EHSI President seeks new medical technologies and investment opportunities in Poland

Emerging Healthcare Solutions President and CEO Cindy Morrissey is in Poland this week to seek out new medical technologies and investment opportunities for the company.

30 Oct 2010

Taligen CEO recognized with Mass High Tech 2010 All-Star Award

Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, announced today that Abbie Celniker, Ph.D., CEO of Taligen Therapeutics was among the recipients of the Mass High Tech, Voice of New England Innovation, 2010 All-Star Awards. The All-Star Awards recognize 16 dynamic and influential leaders of New England's innovation economy. This is the 15th year of the awards program.

30 Oct 2010

Experts at XXXIII World Congress present new clinical challenges about thrombotic disorders

Pharmaceutical Strategic Initiatives announced today that some of the leading experts in the field of thrombosis and anticoagulation provided their perspective and assessment of new clinical challenges at a recent symposium held at the XXXIII World Congress of the International Society of Hematology held in Jerusalem, Israel on October 12, 2010.

30 Oct 2010

Chicago to host BIO International Convention again in 2013 and 2016

The Biotechnology Industry Organization (BIO) today announces that the BIO International Convention - the global event for biotechnology - will return to Chicago, Ill. in 2013 and 2016.

30 Oct 2010

HDL and Virginia governor announce $4.2 million investment for expanding operations

Health Diagnostic Laboratory (HDL, Inc.) and Governor Bob McDonnell have announced an investment of $4.2 million in HDL, Inc. operations, resulting in the creation of 213 new jobs in the City of Richmond. HDL, Inc., located in the Virginia BioTechnology Research Park, will expand its clinical laboratory, diagnostics and clinical trial services, as well as its physician/patient consulting.

30 Oct 2010

NIH director receives Mid-Atlantic Bio Lifetime Achievement Award

The 2010 Mid-Atlantic Bio Conference debuted yesterday with an opening reception during which National Institutes of Health (NIH) Director Francis S. Collins, MD, PhD, was honored with the Mid-Atlantic Bio Lifetime Achievement Award for his accomplishments in biomedical research and human services and his movement to increase translational work at NIH.

30 Oct 2010

Advaxis enters CRADA with NCI for development of live attenuated Listeria vaccines

Advaxis, Inc.,, the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, is pleased to announce it has signed a formal research agreement with the National Cancer Institute at the National Institutes of Health.

30 Oct 2010

Agilent opens new life sciences instruments manufacturing facility in Singapore

Agilent Technologies Inc. today announced the opening of its new life sciences instruments manufacturing facility in Singapore. The facility will produce the company's Liquid Chromatography/Mass Spectrometry (LC/MS) instruments for the global market.

30 Oct 2010

Life Technologies and BGI partner to offer whole human genome resequencing on SOLiD™ 4 System

Life Technologies Corporation and BGI (formerly Beijing Genomics Institute) announced today that they have partnered to offer whole human genome resequencing on the SOLiD™ 4 System. BGI, one of the world's largest genomic centers, has acquired 27 SOLiD 4 Systems, which will allow BGI to deliver 50 whole human genome sequences a month.

29 Oct 2010

Compugen signs oncology research collaboration agreement with Seattle Genetics

Compugen Ltd. announced today that it has signed a research collaboration agreement with Seattle Genetics, Inc., USA, covering a Compugen-discovered oncology target. The agreement provides Seattle Genetics with an initial evaluation period and an option for an exclusive worldwide milestone and royalty bearing license for development and commercialization of monoclonal antibody therapeutics addressing this novel target.

29 Oct 2010

Mary Ann Liebert launches Brain Connectivity journal

Mary Ann Liebert, Inc. announces the release of a new peer-reviewed journal in an expanding area of systems neuroscience, Brain Connectivity. This timely new journal is positioned to become the premier source of cutting-edge basic and clinical neuroscience research aimed at better understanding of structural and functional connections in the brain and how these connections are altered by neurological disorders.

29 Oct 2010

CAN launches Highly Qualified Consumer Database about arthritis

Over 4 million Canadians suffer from arthritis, but only a tiny percentage of them are involved in influencing arthritis research in Canada. The Consumer Advisory Council (CAC) of the Canadian Arthritis Network (CAN) hopes to change that by launching a Highly Qualified Consumer (HQC) Database that will store information about Canadians willing to volunteer as consultants or collaborators to arthritis researchers.

29 Oct 2010

Maxygen sells MolecularBreeding platform technology to Codexis for $20M

Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that it has sold its MolecularBreeding™ platform technology to Codexis, Inc. for $20 million in cash.

29 Oct 2010

DiaGenic third quarter income increases from NOK -9.3 million to NOK -9.6 million

DiaGenic: The interim report for the third quarter 2010 was approved by the Board of Directors on 28 October 2010.

29 Oct 2010

Research on sheep population could help explain variation in vaccine protection

Strong immunity may play a key role in determining long life, but may do so at the expense of reduced fertility, a Princeton University study has concluded.

29 Oct 2010

Baxter to divest U.S. generic injectables business to Hikma

Baxter International Inc. announced today that it has entered into a definitive agreement to divest its U.S. generic injectables business to Hikma Pharmaceuticals PLC. The consideration for the divestiture arrangement totals approximately $112 million, subject to closing adjustments.

From Baxter International Inc. 29 Oct 2010

Biotechnology News and Research

Scientists use electron microscopes to study mechanism of perforin protein to punch holes in rogue cells

Anadys presents data of ANA598 for hepatitis C treatment at AASLD Annual Meeting

2010 Mid-Atlantic Bio a great kick-off for hosting 2011 BIO International Convention

Special issue of Ecopsychology outlines woman's self-perception and behavior

EHSI President seeks new medical technologies and investment opportunities in Poland

Taligen CEO recognized with Mass High Tech 2010 All-Star Award

Experts at XXXIII World Congress present new clinical challenges about thrombotic disorders

Chicago to host BIO International Convention again in 2013 and 2016

HDL and Virginia governor announce $4.2 million investment for expanding operations

NIH director receives Mid-Atlantic Bio Lifetime Achievement Award

Advaxis enters CRADA with NCI for development of live attenuated Listeria vaccines

Agilent opens new life sciences instruments manufacturing facility in Singapore

Life Technologies and BGI partner to offer whole human genome resequencing on SOLiD™ 4 System

Compugen signs oncology research collaboration agreement with Seattle Genetics

Mary Ann Liebert launches Brain Connectivity journal

CAN launches Highly Qualified Consumer Database about arthritis

Maxygen sells MolecularBreeding platform technology to Codexis for $20M

DiaGenic third quarter income increases from NOK -9.3 million to NOK -9.6 million

Research on sheep population could help explain variation in vaccine protection

Baxter to divest U.S. generic injectables business to Hikma

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News